Business Segments MorphoSys AG Xetra

Equities

Market Closed - Xetra Other stock markets 11:36:08 2024-08-02 am EDT			5-day change	1st Jan Change
67.25 ^EUR	-0.66%		-.--%	+97.79%

Aug. 29	MorphoSys AG Announces Changes in the Composition of the Supervisory Board	CI
Aug. 29	MorphoSys AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment

Fiscal Period: December	2019	2020	2021	2022	2023
Life Sciences Tools and Services
Partnered Discovery	37.47M	49.07M	-	-	-
Total Assets	22.93M	21.13M	-	-	-
CAPEX	-625K	-429K	-	-	-
EBT	-	37.42M	-	-	-
D&A	1.38M	1.1M	-	-	-
Operating Income	26.8M	37.42M	-	-	-
Biological Products
Proprietary Development	34.29M	279M	-	-	-
Total Assets	85.08M	242M	-	-	-
CAPEX	-2.83M	-48.26M	-	-	-
EBT	-	59.41M	-	-	-
D&A	1.72M	3.2M	-	-	-
Operating Income	-109M	13.47M	-	-	-
Total Assets	388M	1.4B	-	-	-
CAPEX	-207K	-526K	-	-	-
EBT	-	-73.64M	-	-	-
D&A	355K	425K	-	-	-
Operating Income	-25.72M	-32.94M	-	-	-
EBT	-	-702K	-	-	-

Geographical breakdown of sales

Fiscal Period: December	2019	2020	2021	2022	2023
USA	-	-	-	-	211M
Total Assets	4.4M	8.3M	1.1B	1.17B	1.12B
CAPEX	-1.3M	-1.6M	-1.7M	-	-
Europe (Excluding Germany)	-	-	-	-	26.79M
Asia	-	-	-	-	8K
USA and Canada	32.29M	319M	156M	249M	-
Total Assets	12.5M	-	-	-	-
CAPEX	-100K	-100K	-	-	-
Germany	145K	-	-	-	-
Total Assets	176M	312M	133M	143M	90.6M
CAPEX	-2.3M	-47.6M	-24.5M	-15.2M	-2.9M
Europe and Asia	39.32M	8.64M	23.33M	29.34M	-